Followers | 48 |
Posts | 1181 |
Boards Moderated | 0 |
Alias Born | 04/20/2018 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 15, 2018 11:41:15 AM
1) CEO purchased approx. 10M shares spending $140K of his own money. He will not flip these as that would be a huge red flag for the investment community. Ask yourself, how many CEO's of OTC companies actually purchase 10M of their own shares and spend $140K of their own money on their stock?? There is a reason he invested this much and it's not to lose!
2) They have patents pending worth millions of dollars and game changing technology which is ready to commercialize (watch the video).
3) They have proven the viability/efficacy of their game changing technology through completion of trials and received positive results. My mom was an RN at Cedars Sinai and it is a world renowned hospital. UCLA Harbor is a world class research/medical facility. The doctors associated with these institutions are leaders in their chosen fields. They are winners.
4) The AUA conference has not even happened yet. This Friday-Sunday will be Creative Medical Technology (CELZ) opportunity to show the medical community and world what they have developed and proven through trial to now commercialization. It is substantial!
There are additional factors/catalysts which have been posted by others on this board who have done more due diligence on this company than myself.
I rarely post on ihub as I prefer to stay in the background, read and invest according to my own philosophy. I'd encourage folks to cut out the noise and not sell because the stock is up one day and down the next. Know what you are buying and be prepared to wait and be patient and let things unfold over the next week(s) and months. Patience is key.
Let the company you invested in do it's thing. I'm sure it will turn out positive hence I made a sizable investment. If not, it's for factors outside my/our/your control.
A special thank you to posters Fly, Apostle, YoT, Easy and others who bring helpful information and sound reasoning to the readers of this board. OTC is not the Dow or Nasdaq; however, this is one of the only companies I've personally come across who have the ability to be a game changer and promoted to a bigger board or be purchased. Leadership is smart, pragmatic, measured and taking the right steps to ensure the company has the best chance for success.
Let's see what comes from this weekend and then make appropriate adjustments as necessary. Enjoy the day!
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM